TITLEIST CAPITAL, LLC - RECRO PHARMA INC ownership

Back to all holdings Add to watchlist

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
TITLEIST CAPITAL, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q4 2022$260,379
-4.6%
174,751
+4.2%
0.06%
-3.2%
Q3 2022$273,000
+108.4%
167,693
+1.5%
0.06%
+96.9%
Q2 2022$131,000
-59.6%
165,230
-8.3%
0.03%
-50.0%
Q1 2022$324,000
+25.6%
180,093
+19.4%
0.06%
+28.0%
Q4 2021$258,000–150,867–0.05%–
 Download
Other shareholders

There were no reported owners of RECRO PHARMA INC in Q1 2022.

NameSharesValueWeighting ↓
View complete list of RECRO PHARMA INC shareholders